Gabriel Uwaifo, MD
Basic profileGabriel Uwaifo is an Endocrinology/Metabolic physician affiliated with Southern Illinois University School of Medicine. OpenAlex indexes 374 publications with 11,173 citations (h-index 33).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Eli LillyProgram year20251 paymentResearch$59,571
- Eli Lilly and CompanyProgram year202522 payments$2,852
- Alexion Pharmaceuticals, Inc.Program year20251 payment$1,125
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
42.2%Biguanide (metformin)11%Metformin Hcl Er54%Metformin Hcl46%Part D≥46 patientsGLP-1 receptor agonist10.9%Ozempic31%Victoza 3-Pak22%Trulicity18%Mounjaro14%Victoza 2-Pak9%Rybelsus6%Part D<11 patients+ 9 more classes in this area
Hormonal (systemic)
25.9%l-Thyroxine20.6%Levothyroxine Sodium80%Synthroid20%Part D≥115 patientsThyroid Hormone Synthesis Inhibitor1.4%Methimazole100%Part D<11 patients+ 5 more classes in this area
Cardiovascular
16.6%Statin7.7%Atorvastatin Calcium49%Pravastatin Sodium27%Rosuvastatin Calcium24%Part D≥25 patientsACE inhibitor3.4%Lisinopril100%Part D≥28 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Cardiometabolic comorbidities and complications of obesity and chronic kidney disease (CKD)
Journal of Clinical & Translational Endocrinology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
John Flack, MD, MPH
Southern Illinois University School of Medicine
Brendan Stack, MD
Southern Illinois University School of Medicine
Rebecca Larson, MD
Southern Illinois University School of Medicine
Abdul Moiz Hafiz, MD
Southern Illinois University School of Medicine
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”